Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|January 19, 2016
From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II)Luigi Aurelio, Carmen V Scullino, Melissa R Pitman, et al.
Endocrine-Related Cancer|May 2, 2020
CRISP3 expression drives prostate cancer invasion and progressionMarianna Volpert, Luc Furic, Jinghua Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progressionLuc Furic, Liwei Rong, Ola Larsson, et al.
Nature Communications|March 23, 2023
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cellsYuchen Bai, Carolin Gotz, Ginevra Chincarini, et al.
Cancers|July 29, 2020
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to ChemotherapyAikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Reply to: The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cellsSehrish Kanwal, Natalie Brajanovski, Jiajun Zhan, et al.
Frontiers in Medicine|December 5, 2022
AlphaBet: Combination of Radium-223 and [17 7Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)Louise Kostos, James P Buteau, Theresa Yeung, et al.
Genome Research|March 18, 2016
nanoCAGE reveals 5' UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAsValentina Gandin, Laia Masvidal, Laura Hulea, et al.
Oncotarget|December 2, 2014
Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivityItsuhiro Takizawa, Mitchell G Lawrence, Preetika Balanathan, et al.
The Journal of Biological Chemistry|April 27, 2018
AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965Toby A Dite, Christopher G Langendorf, Ashfaqul Hoque, et al.
Pageof 5